Objective: Glioblastoma (GBM) is a high-grade glial tumor with an aggressive clinical course. Despite multimodal treatment approaches, the clinical outcome is dismal and further therapeutic concepts are needed. Vaccination therapy using autologous dendritic cells (DC) has become a promising approach.[for full text, please go to the a.m. URL] 66. Jahrestagung der Deutschen Gesellschaft für Neurochirurgie (DGNC)
